-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
Supplementary Figure 7 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
32
Supplementary Figure 4 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
33
Supplementary Figure 3 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
34
Supplementary Figure 5 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
35
Supplementary Figure 6 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
36
Supplementary Figure 9 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
37
Table S8 from Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Baskı/Yayın Bilgisi 2025Konular: -
38
Supplementary Figure 8 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
39
Supplementary Figure 2 from Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Baskı/Yayın Bilgisi 2025Konular: -
40